http://www.vivabioinnovator.com http://www.vivabioinnovator.com/cn/about-us-cn http://www.vivabioinnovator.com/cn/cn-home http://www.vivabioinnovator.com/cn/cn-portfolio http://www.vivabioinnovator.com/cn/cn-team http://www.vivabioinnovator.com/cn/contact-us-chinese http://www.vivabioinnovator.com/cn/news http://www.vivabioinnovator.com/en/about-us http://www.vivabioinnovator.com/en/contact-us http://www.vivabioinnovator.com/en/news http://www.vivabioinnovator.com/en/portfolio http://www.vivabioinnovator.com/en/team http://www.vivabioinnovator.com/search http://www.vivabioinnovator.com/style-guide http://www.vivabioinnovator.com/modality/genes-cell-therapy http://www.vivabioinnovator.com/modality/macromolecule http://www.vivabioinnovator.com/modality/other http://www.vivabioinnovator.com/modality/small-molecule http://www.vivabioinnovator.com/indication/cardiovascular http://www.vivabioinnovator.com/indication/cns-infection http://www.vivabioinnovator.com/indication/dermatology http://www.vivabioinnovator.com/indication/immunology http://www.vivabioinnovator.com/indication/infectious http://www.vivabioinnovator.com/indication/metabolic http://www.vivabioinnovator.com/indication/oncology http://www.vivabioinnovator.com/indication/ophthalmology http://www.vivabioinnovator.com/indication/others http://www.vivabioinnovator.com/news/2021-vbi-demo-day-review-gun-ind-and-beyond-presenting-highlights-from-6-vbi-portfolio-companies http://www.vivabioinnovator.com/news/2023-jpmorgan-week-gun-reaching-beyond-the-low-hanging-fruits-in-drug-discovery http://www.vivabioinnovator.com/news/abm-announces-first-patient-dosed-in-phase-i-clinical-trial-of-mek-inhibitor-for-solid-tumor http://www.vivabioinnovator.com/news/abm-therapeutics-abm-1310-granted-fast-track-designation-by-the-fda-following-orphan-drug-designation http://www.vivabioinnovator.com/news/abm-therapeutics-and-sansheng-pharmaceuticals-announced-a-strategic-cooperation-to-accelerate-the-development-of-innovative-drugs http://www.vivabioinnovator.com/news/abm-therapeutics-announces-first-patient-dosed-in-phase-1-clinical-trial http://www.vivabioinnovator.com/news/abm-therapeutics-announces-first-patient-dosed-in-phase-i-clinical-trial-of-abm-1310-in-china http://www.vivabioinnovator.com/news/abm-therapeutics-announces-first-patient-dosed-in-phase-i-study-of-abm-1310-in-patients-with-braf-v600-in-relapsed-and-drug-resistant-primary-malignant-brain-tumors http://www.vivabioinnovator.com/news/abm-therapeutics-has-completed-a-round-financing-of-20-million-us-dollars http://www.vivabioinnovator.com/news/abm-therapeutics-receives-ind-approval-by-fda-for-mek-inhibitor-abm-168 http://www.vivabioinnovator.com/news/abm-therapeutics-receives-ind-approval-in-china-for-mek-inhibitor-abm-168 http://www.vivabioinnovator.com/news/absci-was-successfully-listed-on-nasdaq http://www.vivabioinnovator.com/news/acelink-opens-first-clinical-site-in-china-for-phase-2-study-in-fabry-disease http://www.vivabioinnovator.com/news/acelink-presented-phase-i-clinical-data-of-al01211-and-al00804-during-the-2023-world-symposium http://www.vivabioinnovator.com/news/acelink-therapeutics-announces-publication-of-phase-1-clinical-trial-data-evaluating-al01211-in-healthy-volunteers http://www.vivabioinnovator.com/news/acelink-therapeutics-receives-orphan-drug-designation-for-its-novel-gcs-inhibitor-al01211-for-the-treatment-of-fabry-disease http://www.vivabioinnovator.com/news/acurastem-enters-into-a-license-agreement-with-takeda-to-advance-pikfyve-therapeutics http://www.vivabioinnovator.com/news/aixplorerbio-and-paddlehelix-reached-a-deep-collaboration-to-promote-the-construction-of-ai-small-molecule-drug-r-d-system http://www.vivabioinnovator.com/news/aixplorerbio-and-the-institute-of-immunology-at-tsinghua-university-reached-a-strategic-collaboration-agreement-to-explore-and-promote-the-r-d-of-new-drugs-in-the-field-of-autoimmunity http://www.vivabioinnovator.com/news/aleta-biotherapeutics-receives-innovation-passport-designation-for-biologic-car-t-cell-therapy-engager-aleta-001 http://www.vivabioinnovator.com/news/amacathera-announces-close-of-oversubscribed-series-a-financing http://www.vivabioinnovator.com/news/amacathera-closes-series-a-extension-to-advance-clinical-development-of-long-acting-localized-non-opioid-therapeutics-to-improve-post-surgery-patient-care http://www.vivabioinnovator.com/news/amacathera-doses-first-subjects-in-phase-1-clinical-trial-for-amacagel-tm-therapeutic-platform http://www.vivabioinnovator.com/news/amacathera-named-cix-top-20-early-company http://www.vivabioinnovator.com/news/amacatheras-lung-cancer-applications-recognized-in-quickfire-challenge http://www.vivabioinnovator.com/news/amberstone-biosciences-announces-formation-of-scientific-advisory-board http://www.vivabioinnovator.com/news/anj900-was-approved-to-launch-key-phase-iii-clinical-trials-in-china http://www.vivabioinnovator.com/news/anji-pharma-and-population-health-partners-enter-into-strategic-collaboration-to-jointly-address-high-prevalence-human-disease http://www.vivabioinnovator.com/news/anji-pharma-launches-phase-3-trial-for-anj900 http://www.vivabioinnovator.com/news/anji-pharma-provides-updates-on-two-lead-programs http://www.vivabioinnovator.com/news/anji-pharmaceutical-accelerates-phase-ii-clinical-study-of-anj908 http://www.vivabioinnovator.com/news/anji-to-advance-mcl1-inhibitor-program-from-broad-institute-into-clinical-trials http://www.vivabioinnovator.com/news/antag-therapeutics-announces-fda-clearance-of-investigational-new-drug-ind-application-for-leadmolecule-at-7687 http://www.vivabioinnovator.com/news/apeiron-closes-17-5-million-series-a-and-launches-new-strategic-partnerships-with-viva-biotech http://www.vivabioinnovator.com/news/arrepath-announces-20-million-seed-financing-to-advance-its-machine-learning-based-platform-for-discovery-of-novel-anti-infectives-addressing-antimicrobial-resistance http://www.vivabioinnovator.com/news/arthrosi-announces-positive-topline-results-for-ar882-phase-2b-study http://www.vivabioinnovator.com/news/arthrosi-completes-ar882-renal-impairment-study http://www.vivabioinnovator.com/news/arthrosi-secures-75m-in-series-d-financing http://www.vivabioinnovator.com/news/arthrosi-therapeutics-ar882-prepares-to-enter-into-global-phase-3-study http://www.vivabioinnovator.com/news/arthrosi-therapeutics-completed-round-c-financing http://www.vivabioinnovator.com/news/arthrosi-therapeutics-inc-announces-patient-enrollment-in-global-phase-2b-study-of-ar882 http://www.vivabioinnovator.com/news/arthrosi-therapeutics-released-phase-2-clinical-data-of-ar882 http://www.vivabioinnovator.com/news/arthrosi-to-present-positive-phase-2-data-for-its-novel-selective-urat1-inhibitor-ar882-in-patients-with-tophaceous-gout-at-acr-convergence-2023 http://www.vivabioinnovator.com/news/as-both-investor-and-cro-viva-enjoys-another-fruitful-year-at-jpm http://www.vivabioinnovator.com/news/basking-biosciences-announces-close-of-55-million-financing-to-accelerate-clinical-development-for-first-reversible-thrombolytic-for-ischemic-stroke http://www.vivabioinnovator.com/news/basking-biosciences-presents-positive-clinical-results-from-safety-and-dose-escalation-study-for-first-reversible-thrombolytic-agent-at-isc-2023 http://www.vivabioinnovator.com/news/basking-biosciences-to-present-clinical-trial-results-on-first-reversible-thrombolytic-agent-at-american-heart-association-international-stroke-conference-2023 http://www.vivabioinnovator.com/news/cybrexa-therapeutics-announces-data-demonstrating-early-signals-of-efficacy-and-powerful-potential-of-antigen-independent-tumor-targeting http://www.vivabioinnovator.com/news/cybrexa-therapeutics-announces-positive-final-data-at-esmo-2024-from-phase-1-study-of-peptide-drug-conjugate-cbx-12-in-advanced-solid-tumors http://www.vivabioinnovator.com/news/deka-biosciences-closes-usd-20-million-series-b2-financing-led-by-mpm-bioimpact http://www.vivabioinnovator.com/news/deka-biosciences-raises-usd-20-million-in-series-a-financing http://www.vivabioinnovator.com/news/dogma-therapeutics-reached-the-acquisition-agreement-with-astrazeneca-on-dogmas-oral-pcsk9-inhibitor-program http://www.vivabioinnovator.com/news/domain-therapeutics-announces-nomination-of-first-in-class-par2-nam-candidate-dt-9045-to-unlock-new-cancer-treatment-possibilities http://www.vivabioinnovator.com/news/domain-therapeutics-raises-42m-series-a-financing http://www.vivabioinnovator.com/news/domain-therapeutics-receives-a-single-digit-multimillion-development-milestone-payment-from-merck-for-m1069-clinical-development-in-immuno-oncology http://www.vivabioinnovator.com/news/domain-therapeutics-to-progress-into-clinical-trials-with-its-ep4r-antagonist-dt-9081-in-solid-tumors http://www.vivabioinnovator.com/news/dr-david-xu-innovative-drugs-must-effectively-address-unmet-clinical-needs http://www.vivabioinnovator.com/news/dr-kasper-roet-ceo-of-quralis-selected-for-the-2022-henri-termeer-award http://www.vivabioinnovator.com/news/dtx-pharma-completes-10-6m-series-a-financing http://www.vivabioinnovator.com/news/dtx-pharma-completes-100m-series-b-financing http://www.vivabioinnovator.com/news/dtx-pharma-reached-the-acquisition-agreement-with-novartis http://www.vivabioinnovator.com/news/dtx-pharma-receives-fda-orphan-drug-designation-for-dtx-1252-for-the-treatment-of-charcot-marie-tooth-disease-type-1a-cmt1a http://www.vivabioinnovator.com/news/eli-lilly-backed-ipinovyx-bio-emerges-with-10m-for-2023-clinical-entry http://www.vivabioinnovator.com/news/endpts-looking-to-rewrite-the-rules-of-drug-licensing-startup-anji-is-on-the-hunt-for-dynamic-equity-joint-ventures http://www.vivabioinnovator.com/news/everything-you-need-to-know-about-viva-biotech-2022-annual-results http://www.vivabioinnovator.com/news/exclusive-interview-with-focus-x-therapeutics-achieving-successful-acquisition-within-two-years-of-establishment-what-makes-this-radiopharmaceutical-start-up-stand-out http://www.vivabioinnovator.com/news/exelixis-and-cybrexa-therapeutics-establish-exclusive-collaboration-providing-exelixis-the-right-to-acquire-cbx-12-a-potential-first-in-class-peptide-drug-conjugate-of-exatecan http://www.vivabioinnovator.com/news/focus-x-therapeutics-a-viva-biotech-portfolio-company-successfully-reached-an-acquisition-agreement-with-full-life-technologies http://www.vivabioinnovator.com/news/full-life-technologies-sk-biopharmaceuticals-enter-licensing-agreement-for-novel-therapeutic-targeting-multiple-solid-tumors http://www.vivabioinnovator.com/news/fuse-biotherapeutics-raises-an-oversubscribed-and-upsized-seed-financing-round-of-9-5-million http://www.vivabioinnovator.com/news/haya-included-in-the-top-15-swiss-biotech-startups-making-a-difference-in-europe http://www.vivabioinnovator.com/news/haya-therapeutics-announces-collaboration-with-lilly-to-discover-novel-regulatory-genome-targets-for-obesity-and-related-metabolic-conditions-using-proprietary-rna-platform http://www.vivabioinnovator.com/news/haya-therapeutics-won-the-top-100-swiss-startup-award-2022-and-was-successfully-selected-for-soonicorn-club-2022 http://www.vivabioinnovator.com/news/hengrui-medicines-apatinib-and-qiyu-bio-q-1802-announced-a-strategic-cooperation-for-a-phase-ii-clinical-study-of-advanced-gastric-cancer http://www.vivabioinnovator.com/news/join-vbi-and-j-j-on-dec-8-with-the-the-dos-donts-of-fundraising http://www.vivabioinnovator.com/news/joint-fight-against-covid-19-viva-biotech-contributes-to-the-production-of-the-oral-covid-19-antiviral-medication-and-virus-tests http://www.vivabioinnovator.com/news/langhua-pharmaceuticals-cmc-business-came-to-the-fore http://www.vivabioinnovator.com/news/latest-updates-of-3-vivas-portfolio-companies http://www.vivabioinnovator.com/news/latest-updates-of-5-vivas-portfolio-companies http://www.vivabioinnovator.com/news/latest-updates-of-6-vivas-portfolio-companies http://www.vivabioinnovator.com/news/latest-updates-of-9-vivas-portfolio-companies http://www.vivabioinnovator.com/news/latest-updates-of-viva-biotechs-portfolio-companies http://www.vivabioinnovator.com/news/latest-updates-of-viva-biotechs-portfolio-companies-2 http://www.vivabioinnovator.com/news/latest-updates-of-viva-biotechs-portfolio-companies-3 http://www.vivabioinnovator.com/news/latest-updates-of-viva-biotechs-portfolio-companies-4 http://www.vivabioinnovator.com/news/latest-updates-of-viva-biotechs-portfolio-companies-5 http://www.vivabioinnovator.com/news/latest-updates-of-vivas-portfolio-companies http://www.vivabioinnovator.com/news/latest-updates-of-vivas-portfolio-companies-2 http://www.vivabioinnovator.com/news/latest-updates-of-vivas-portfolio-companies-3 http://www.vivabioinnovator.com/news/latest-updates-of-vivas-portfolio-companies-4 http://www.vivabioinnovator.com/news/latest-updates-of-vivas-portfolio-companies-5 http://www.vivabioinnovator.com/news/lucy-therapeutics-secures-new-funding-to-advance-new-alzheimers-and-parkinsons-treatments http://www.vivabioinnovator.com/news/mediar-therapeutics-announces-105-million-financing-to-advance-portfolio-of-first-in-class-fibrosis-therapies http://www.vivabioinnovator.com/news/meet-abm-therapeutics-at-aacr-annual-meeting-2020 http://www.vivabioinnovator.com/news/nerio-therapeutics-a-viva-biotechs-portfolio-company-was-successfully-acquired-by-boehringer-ingelheim-for-1-3-billion http://www.vivabioinnovator.com/news/on-a-quest-to-solve-the-biggest-problem-in-stroke-therapy http://www.vivabioinnovator.com/news/phenomic-ai-the-biotech-business-harnessing-the-power-of-ai http://www.vivabioinnovator.com/news/phenomic-enters-into-strategic-research-collaboration-with-astellas-for-solid-tumor-cell-therapies http://www.vivabioinnovator.com/news/phenomic-enters-strategic-collaboration-with-boehringer-ingelheim-to-discover-novel-targets-for-stroma-rich-cancer-therapies http://www.vivabioinnovator.com/news/quralis-closes-88-million-series-b-financing-to-advance-precision-medicines-for-neurodegenerative-diseases http://www.vivabioinnovator.com/news/quralis-grants-lilly-exclusive-global-license-for-qrl-204-a-potentially-first-in-class-precision-therapy-that-restores-unc13a-function-in-als-and-ftd http://www.vivabioinnovator.com/news/quralis-included-in-the-fierce-biotech-2020-fierce-15-list http://www.vivabioinnovator.com/news/quralis-raises-42-million-series-a-financing-to-develop-new-therapies http://www.vivabioinnovator.com/news/qurebio-announces-the-enrollment-of-first-patient-in-phase-i-clinical-trial http://www.vivabioinnovator.com/news/qurebio-biotechnology-completes-series-a-financing http://www.vivabioinnovator.com/news/qurebio-completes-series-a-and-begins-to-move-into-the-clinical-stage http://www.vivabioinnovator.com/news/qurebio-ltd-to-showcase-its-q-1802-clinical-advances-at-2022-asco-annual-meetings http://www.vivabioinnovator.com/news/qurebio-q-1801-project-was-approved-by-cde http://www.vivabioinnovator.com/news/qurebios-first-bispecific-antibody-q-1802-combination-clinical-trial-phase-i-ii-was-approved http://www.vivabioinnovator.com/news/qurebios-q-1802-clinical-application-accepted-by-nmpa http://www.vivabioinnovator.com/news/r-s-v-p-viva-biotech-2022-partnership-summit http://www.vivabioinnovator.com/news/regenacy-pharmaceuticals-announces-completion-of-enrollment-for-phase-2-study-in-diabetic-peripheral-neuropathy-9-3-million-series-b-financing http://www.vivabioinnovator.com/news/riparian-pharmaceuticals-announces-exclusive-license-agreement-and-research-agreement-with-pfizer-for-novel-cardiovascular-programs http://www.vivabioinnovator.com/news/seraxis-announces-fda-ind-allowance-for-clinical-study-of-sr-02-replacement-islets-for-type-1-diabetes http://www.vivabioinnovator.com/news/shanghai-epn-and-biomap-reached-a-strategic-cooperation http://www.vivabioinnovator.com/news/simon-sturge-joins-mediar-therapeutics-as-executive-chairman http://www.vivabioinnovator.com/news/technoderma-announced-new-progress-in-phase-i-clinical-trials-of-tdm-105795-in-the-u-s http://www.vivabioinnovator.com/news/technoderma-completed-the-series-a-funding-of-tens-of-millions-of-rmb http://www.vivabioinnovator.com/news/technoderma-medicines-announced-the-completion-of-series-a-financing http://www.vivabioinnovator.com/news/technoderma-medicines-initiates-tdm-105795-androgenetic-alopecia-phase-2-clinical-trial http://www.vivabioinnovator.com/news/technoderma-medicines-initiates-tdm-180935-atopic-dermatitis-clinical-program-with-phase-1-dose-escalation-trial http://www.vivabioinnovator.com/news/the-interview-of-cheney-mao-chairman-ceo-of-viva-biotech http://www.vivabioinnovator.com/news/the-phase-ii-clinical-trial-application-of-vvn461-for-the-treatment-of-postoperative-inflammation-in-cataract-was-approved-by-the-u-s-fda http://www.vivabioinnovator.com/news/the-u-s-food-and-drug-administration-granted-ind-approval-for-q-1802 http://www.vivabioinnovator.com/news/totient-a-viva-biotech-portfolio-company-achieves-the-acquisition-with-absci http://www.vivabioinnovator.com/news/triumvira-immunologics-completes-extension-of-series-a-financing-for-total-round-of-approximately-100-million http://www.vivabioinnovator.com/news/triumvira-immunologics-establishes-collaboration-with-merck-to-evaluate-tac01-her2-cell-therapy-in-combination-with-keytruda-r-pembrolizumab-in-patients-with-her2-positive-solid-tumors http://www.vivabioinnovator.com/news/triumvira-is-creating-a-different-picture-for-cancer-patients http://www.vivabioinnovator.com/news/u-s-fda-grants-orphan-drug-designation-to-abm-1310-for-the-treatment-of-patients-with-glioblastoma-harboring-braf-v600-mutation http://www.vivabioinnovator.com/news/vbi-attended-china-partnerships-panel-at-resi-boston http://www.vivabioinnovator.com/news/vbi-demoday-on-oct-29th http://www.vivabioinnovator.com/news/vbi-strengthens-ties-with-innovators-for-three-days-of-action-packed-meetings http://www.vivabioinnovator.com/news/viva-bioinnovator-vbi-successfully-held-demo-day-2 http://www.vivabioinnovator.com/news/viva-bioinnovator-vbi-successfully-held-first-demo-day http://www.vivabioinnovator.com/news/viva-bioinnovator-venture-day-with-newyorkbio-biocom-california http://www.vivabioinnovator.com/news/viva-bioinnovator-was-listed-as-the-first-batch-of-gois http://www.vivabioinnovator.com/news/viva-biotech-1873-hk-announces-2019-annual-results http://www.vivabioinnovator.com/news/viva-biotech-1873-hk-announces-2019-annual-results-2 http://www.vivabioinnovator.com/news/viva-biotech-and-alphama-reached-cooperation-agreement-on-intelligentdel-idel http://www.vivabioinnovator.com/news/viva-biotech-and-biomap-reached-a-strategic-collaboration-agreement http://www.vivabioinnovator.com/news/viva-biotech-and-langhua-pharmaceutical-reached-strategic-acquisition-agreement http://www.vivabioinnovator.com/news/viva-biotech-and-schrodinger-announce-strategic-collaboration http://www.vivabioinnovator.com/news/viva-biotech-and-synthesis-enters-a-strategic-acquisition-agreement http://www.vivabioinnovator.com/news/viva-biotech-announced-2020-annual-results-the-groups-revenue-surged-by-115-7-yoy-revenue-from-the-cfs-business-increased-significantly-by-146-3-yoy http://www.vivabioinnovator.com/news/viva-biotech-announced-2020-interim-results-adjusted-net-profit-rose-by-25-yoy http://www.vivabioinnovator.com/news/viva-biotech-announced-2021-interim-results http://www.vivabioinnovator.com/news/viva-biotech-announced-2022-annual-results http://www.vivabioinnovator.com/news/viva-biotech-announces-2021-annual-results http://www.vivabioinnovator.com/news/viva-biotech-announces-strategic-partnership-with-harbour-biomed-hbm http://www.vivabioinnovator.com/news/viva-biotech-annual-appreciation-reception-2019-held-in-boston http://www.vivabioinnovator.com/news/viva-biotech-awarded-2021-greater-china-cro-entrepreneurial-company-of-the-year http://www.vivabioinnovator.com/news/viva-biotech-awarded-top-10-public-companies http://www.vivabioinnovator.com/news/viva-biotech-enters-strategic-collaboration-with-biocytogen http://www.vivabioinnovator.com/news/viva-biotech-holdings-1873-hk-announces-2019-interim-results http://www.vivabioinnovator.com/news/viva-biotech-online-investor-day-review http://www.vivabioinnovator.com/news/viva-biotech-partnership-summit-2019-successfully-launched http://www.vivabioinnovator.com/news/viva-biotech-successfully-held-2021-partnership-summit http://www.vivabioinnovator.com/news/viva-biotech-successfully-held-the-3rd-annual-partnership-summit http://www.vivabioinnovator.com/news/viva-biotech-supports-the-sabpa-e-club-medicinal-chemistry-symposium http://www.vivabioinnovator.com/news/viva-jointly-build-medical-innovation-achievement-transformation-platform http://www.vivabioinnovator.com/news/vivavision-and-acemab-reached-a-strategic-collaboration-agreement-to-jointly-develop-antibody-drugs-for-fundus-diseases http://www.vivabioinnovator.com/news/vivavision-and-everads-collaborate-to-develop-durable-and-effective-therapies-for-retinal-diseases http://www.vivabioinnovator.com/news/vivavision-announced-the-completion-of-over-100-million-rmb-in-series-d2-financing http://www.vivabioinnovator.com/news/vivavision-announces-that-vvn539-has-been-formally-submitted-for-u-s-phase-ii-clinical-trial-application http://www.vivabioinnovator.com/news/vivavision-biotech-announces-positive-top-line-results-of-vvn001-in-the-phase-2-clinical-study-for-the-treatment-of-dry-eye-disease http://www.vivabioinnovator.com/news/vivavision-completed-300-million-rmb-series-d-financing http://www.vivabioinnovator.com/news/vivavision-submitted-lfa1-inhibitor-vvn001-clinical-phase-ii-trial-application http://www.vivabioinnovator.com/news/vvn539-a-dual-target-innovative-drug-for-glaucoma-independently-developed-by-vivavision-reached-the-primary-research-endpoint-in-the-phase-ii-clinical-trial-in-the-united-states http://www.vivabioinnovator.com/team-member-chinese/cheney-mao-ph-d http://www.vivabioinnovator.com/team-member-chinese/cynthia-cai-ph-d-mba http://www.vivabioinnovator.com/team-member-chinese/daniel-mao http://www.vivabioinnovator.com/team-member-chinese/derek-ren-ph-d http://www.vivabioinnovator.com/team-member-chinese/elena-ma-ph-d http://www.vivabioinnovator.com/team-member-chinese/guanghui-hu http://www.vivabioinnovator.com/team-member-chinese/guoliang-li http://www.vivabioinnovator.com/team-member-chinese/han-dai-ph-d http://www.vivabioinnovator.com/team-member-chinese/jianhua-cai-ph-d http://www.vivabioinnovator.com/team-member-chinese/jie-wang-ph-d http://www.vivabioinnovator.com/team-member-chinese/katie-zhou-aicpa http://www.vivabioinnovator.com/team-member-chinese/ted-dong http://www.vivabioinnovator.com/team-member-chinese/wendy-duan http://www.vivabioinnovator.com/team-member-chinese/yinghong-gao http://www.vivabioinnovator.com/team-member-chinese/zhixiong-ye-ph-d http://www.vivabioinnovator.com/team-member/cheney-mao-ph-d http://www.vivabioinnovator.com/team-member/cynthia-cai-ph-d-mba http://www.vivabioinnovator.com/team-member/daniel-mao http://www.vivabioinnovator.com/team-member/derek-ren-ph-d http://www.vivabioinnovator.com/team-member/elena-ma-ph-d http://www.vivabioinnovator.com/team-member/guanghui-hu http://www.vivabioinnovator.com/team-member/guoliang-li http://www.vivabioinnovator.com/team-member/han-dai-ph-d http://www.vivabioinnovator.com/team-member/jianhua-cai-ph-d http://www.vivabioinnovator.com/team-member/jie-wang-ph-d http://www.vivabioinnovator.com/team-member/katie-zhou-aicpa http://www.vivabioinnovator.com/team-member/ted-dong http://www.vivabioinnovator.com/team-member/wendy-duan http://www.vivabioinnovator.com/team-member/yinghong-gao http://www.vivabioinnovator.com/team-member/zhixiong-ye-ph-d http://www.vivabioinnovator.com/portfolio/abm-therapeutics http://www.vivabioinnovator.com/portfolio/acelink-therapeutics http://www.vivabioinnovator.com/portfolio/acurastem http://www.vivabioinnovator.com/portfolio/aleta-biotherapeutics http://www.vivabioinnovator.com/portfolio/amacathera http://www.vivabioinnovator.com/portfolio/amberstone-biosciences http://www.vivabioinnovator.com/portfolio/anji-pharmaceuticals http://www.vivabioinnovator.com/portfolio/antag-therapeutics http://www.vivabioinnovator.com/portfolio/argonaut-genomics http://www.vivabioinnovator.com/portfolio/arrepath http://www.vivabioinnovator.com/portfolio/arthrosi-therapeutics http://www.vivabioinnovator.com/portfolio/basking-bioscience http://www.vivabioinnovator.com/portfolio/biocasting-pharma http://www.vivabioinnovator.com/portfolio/blue-oak-pharmaceuticals http://www.vivabioinnovator.com/portfolio/bonti http://www.vivabioinnovator.com/portfolio/bright-angel-therapeutics http://www.vivabioinnovator.com/portfolio/calira-therapeutics http://www.vivabioinnovator.com/portfolio/clues-therapeutics http://www.vivabioinnovator.com/portfolio/cybrexa http://www.vivabioinnovator.com/portfolio/deka-biosciences http://www.vivabioinnovator.com/portfolio/dogma-therapeutics http://www.vivabioinnovator.com/portfolio/domain-therapeutics http://www.vivabioinnovator.com/portfolio/dorian-2 http://www.vivabioinnovator.com/portfolio/dtx-pharma http://www.vivabioinnovator.com/portfolio/elgia-therapeutics http://www.vivabioinnovator.com/portfolio/epican-technology http://www.vivabioinnovator.com/portfolio/eubulus http://www.vivabioinnovator.com/portfolio/evexia-therapetucs http://www.vivabioinnovator.com/portfolio/exarta-therapeutics http://www.vivabioinnovator.com/portfolio/f5-therapeutics http://www.vivabioinnovator.com/portfolio/flash-therapeutics http://www.vivabioinnovator.com/portfolio/focus-x-therapeutics http://www.vivabioinnovator.com/portfolio/forkhead-biotherapeutics http://www.vivabioinnovator.com/portfolio/full-circles http://www.vivabioinnovator.com/portfolio/fuse-biotherapeutics http://www.vivabioinnovator.com/portfolio/genhouse http://www.vivabioinnovator.com/portfolio/grove-biopharma http://www.vivabioinnovator.com/portfolio/gt-apeiron-therapeutics http://www.vivabioinnovator.com/portfolio/haya-therapeutics http://www.vivabioinnovator.com/portfolio/i2o-therapeutics http://www.vivabioinnovator.com/portfolio/ipinovyx http://www.vivabioinnovator.com/portfolio/iterion-therapeutics http://www.vivabioinnovator.com/portfolio/jia-xing-suo-zhi-sheng-wu-ke-ji-aixplorerbio http://www.vivabioinnovator.com/portfolio/karma-biotechnologies http://www.vivabioinnovator.com/portfolio/liang-zhun-xlement http://www.vivabioinnovator.com/portfolio/livati-therapeutics http://www.vivabioinnovator.com/portfolio/mebias-discovery http://www.vivabioinnovator.com/portfolio/mediar-therapeutics http://www.vivabioinnovator.com/portfolio/morphogene http://www.vivabioinnovator.com/portfolio/naki-therapeutics http://www.vivabioinnovator.com/portfolio/nerio-therapeutics http://www.vivabioinnovator.com/portfolio/ophidion http://www.vivabioinnovator.com/portfolio/ornovi http://www.vivabioinnovator.com/portfolio/path-therapeutics http://www.vivabioinnovator.com/portfolio/phenomic-ai http://www.vivabioinnovator.com/portfolio/proviva-therapeutics http://www.vivabioinnovator.com/portfolio/qi-yu-sheng-wu-ji-zhu-qurebio http://www.vivabioinnovator.com/portfolio/quralis http://www.vivabioinnovator.com/portfolio/regenacy-pharmaceuticals http://www.vivabioinnovator.com/portfolio/reglagene http://www.vivabioinnovator.com/portfolio/ribogenics http://www.vivabioinnovator.com/portfolio/riparian-pharmaceuticals http://www.vivabioinnovator.com/portfolio/saverna-therapeutics http://www.vivabioinnovator.com/portfolio/seraxis http://www.vivabioinnovator.com/portfolio/sisu-pharma http://www.vivabioinnovator.com/portfolio/synthis-therapeutics http://www.vivabioinnovator.com/portfolio/tabomedex-biosciences http://www.vivabioinnovator.com/portfolio/tatara-therapeutics http://www.vivabioinnovator.com/portfolio/technoderma-medicines http://www.vivabioinnovator.com/portfolio/telo-therapeutics http://www.vivabioinnovator.com/portfolio/tian-jing-sheng-wu-ke-ji-i-mab http://www.vivabioinnovator.com/portfolio/totient http://www.vivabioinnovator.com/portfolio/trio-bio http://www.vivabioinnovator.com/portfolio/triumvira-immunologics http://www.vivabioinnovator.com/portfolio/twin-lanterns http://www.vivabioinnovator.com/portfolio/united-innomed http://www.vivabioinnovator.com/portfolio/versapeutics http://www.vivabioinnovator.com/portfolio/vincere-biosciences http://www.vivabioinnovator.com/portfolio/viva-vision http://www.vivabioinnovator.com/portfolio/wei-qing-sheng-wu-ke-ji-weiqing-bio http://www.vivabioinnovator.com/portfolio/wm-therapeutics http://www.vivabioinnovator.com/portfolio/zing-bio http://www.vivabioinnovator.com/portfolio-chinese/abm-therapeutics http://www.vivabioinnovator.com/portfolio-chinese/acelink-therapeutics http://www.vivabioinnovator.com/portfolio-chinese/acurastem http://www.vivabioinnovator.com/portfolio-chinese/aleta-biosciences http://www.vivabioinnovator.com/portfolio-chinese/amacathera http://www.vivabioinnovator.com/portfolio-chinese/amberstone-biosciences http://www.vivabioinnovator.com/portfolio-chinese/anji-pharmaceuticals http://www.vivabioinnovator.com/portfolio-chinese/antag-therapeutics http://www.vivabioinnovator.com/portfolio-chinese/argonaut-genomics http://www.vivabioinnovator.com/portfolio-chinese/arrepath http://www.vivabioinnovator.com/portfolio-chinese/arthrosi-therapeutics http://www.vivabioinnovator.com/portfolio-chinese/basking-bioscience http://www.vivabioinnovator.com/portfolio-chinese/biocasting-zi-zhan-yi-yao http://www.vivabioinnovator.com/portfolio-chinese/blue-oak-pharmaceuticals http://www.vivabioinnovator.com/portfolio-chinese/bonti http://www.vivabioinnovator.com/portfolio-chinese/bright-angel-therapeutics http://www.vivabioinnovator.com/portfolio-chinese/calira-therapeutics http://www.vivabioinnovator.com/portfolio-chinese/clues-therapeutics http://www.vivabioinnovator.com/portfolio-chinese/cybrexa http://www.vivabioinnovator.com/portfolio-chinese/deka-biosciences http://www.vivabioinnovator.com/portfolio-chinese/dogma-therapeutics http://www.vivabioinnovator.com/portfolio-chinese/domain-therapeutics http://www.vivabioinnovator.com/portfolio-chinese/dorian http://www.vivabioinnovator.com/portfolio-chinese/dtx-pharma http://www.vivabioinnovator.com/portfolio-chinese/elgia-therapeutics http://www.vivabioinnovator.com/portfolio-chinese/epican-technology-limited http://www.vivabioinnovator.com/portfolio-chinese/eubulus http://www.vivabioinnovator.com/portfolio-chinese/evexia-therapetucs http://www.vivabioinnovator.com/portfolio-chinese/exarta-therapeutics http://www.vivabioinnovator.com/portfolio-chinese/f5-therapeutics http://www.vivabioinnovator.com/portfolio-chinese/flash-therapeutics http://www.vivabioinnovator.com/portfolio-chinese/focus-x-therapeutics http://www.vivabioinnovator.com/portfolio-chinese/forkhead-biotherapeutics http://www.vivabioinnovator.com/portfolio-chinese/full-circles http://www.vivabioinnovator.com/portfolio-chinese/fuse-biotherapeutics http://www.vivabioinnovator.com/portfolio-chinese/genhouse http://www.vivabioinnovator.com/portfolio-chinese/grove-biopharma http://www.vivabioinnovator.com/portfolio-chinese/gt-apeiron-therapeutics http://www.vivabioinnovator.com/portfolio-chinese/haya-therapeutics http://www.vivabioinnovator.com/portfolio-chinese/i2o-therapeutics http://www.vivabioinnovator.com/portfolio-chinese/ipinovyx http://www.vivabioinnovator.com/portfolio-chinese/iterion-therapeutics http://www.vivabioinnovator.com/portfolio-chinese/jia-xing-suo-zhi-sheng-wu-ke-ji-aixplorerbio http://www.vivabioinnovator.com/portfolio-chinese/karma-biotechnologies http://www.vivabioinnovator.com/portfolio-chinese/liang-zhun-xlement http://www.vivabioinnovator.com/portfolio-chinese/livati-therapeutics http://www.vivabioinnovator.com/portfolio-chinese/mebias-discovery http://www.vivabioinnovator.com/portfolio-chinese/mediar-therapeutics http://www.vivabioinnovator.com/portfolio-chinese/morphogene http://www.vivabioinnovator.com/portfolio-chinese/naki-therapeutics http://www.vivabioinnovator.com/portfolio-chinese/nerio-therapeutics http://www.vivabioinnovator.com/portfolio-chinese/ophidion http://www.vivabioinnovator.com/portfolio-chinese/ornovi http://www.vivabioinnovator.com/portfolio-chinese/path-therapeutics http://www.vivabioinnovator.com/portfolio-chinese/phenomic-ai http://www.vivabioinnovator.com/portfolio-chinese/proviva-therapeutics http://www.vivabioinnovator.com/portfolio-chinese/qi-yu-sheng-wu-ji-zhu-qurebio http://www.vivabioinnovator.com/portfolio-chinese/quralis http://www.vivabioinnovator.com/portfolio-chinese/regenacy-pharmaceuticals http://www.vivabioinnovator.com/portfolio-chinese/reglagene http://www.vivabioinnovator.com/portfolio-chinese/ribogenics http://www.vivabioinnovator.com/portfolio-chinese/riparian-pharmaceuticals http://www.vivabioinnovator.com/portfolio-chinese/saverna-therapeutics http://www.vivabioinnovator.com/portfolio-chinese/seraxis http://www.vivabioinnovator.com/portfolio-chinese/sisu-pharma http://www.vivabioinnovator.com/portfolio-chinese/synthis-therapeutics http://www.vivabioinnovator.com/portfolio-chinese/tabomedex-biosciences http://www.vivabioinnovator.com/portfolio-chinese/tatara-therapeutics http://www.vivabioinnovator.com/portfolio-chinese/technoderma-medicines-co-jia-xing-te-ke-luo-sheng-wu-ke-ji http://www.vivabioinnovator.com/portfolio-chinese/telo-therapeutics http://www.vivabioinnovator.com/portfolio-chinese/tian-jing-sheng-wu-ke-ji-i-mab http://www.vivabioinnovator.com/portfolio-chinese/totient http://www.vivabioinnovator.com/portfolio-chinese/trio-bio http://www.vivabioinnovator.com/portfolio-chinese/triumvira-immunologics http://www.vivabioinnovator.com/portfolio-chinese/twin-lanterns http://www.vivabioinnovator.com/portfolio-chinese/united-innomed http://www.vivabioinnovator.com/portfolio-chinese/versapeutics http://www.vivabioinnovator.com/portfolio-chinese/vincere-biosciences http://www.vivabioinnovator.com/portfolio-chinese/wei-mou-sheng-wu-ke-ji-vivavision-biotech http://www.vivabioinnovator.com/portfolio-chinese/wei-qing-sheng-wu-ke-ji-weiqing-bio http://www.vivabioinnovator.com/portfolio-chinese/wm-therapeutics http://www.vivabioinnovator.com/portfolio-chinese/zing-bio http://www.vivabioinnovator.com/location/canada http://www.vivabioinnovator.com/location/china http://www.vivabioinnovator.com/location/europe http://www.vivabioinnovator.com/location/others http://www.vivabioinnovator.com/location/us http://www.vivabioinnovator.com/news-cn/13yi-mei-yuan-jiao-yi-wei-ya-sheng-wu-tou-zi-fu-hua-gong-si-nerioyu-bo-lin-ge-yin-ge-han-da-cheng-shou-gou http://www.vivabioinnovator.com/news-cn/2021-vbi-demo-day-hui-gu-gun-6-jia-fu-hua-chu-chuang-qi-ye-liang-dian-su-lan-fu-gai-duo-ge-re-men-ling-yu http://www.vivabioinnovator.com/news-cn/2023-jpmorgan-week-gun-tu-po-yao-wu-kai-fa-de-ping-jing-cheng-yao-nin-de-can-yu http://www.vivabioinnovator.com/news-cn/abm-1310-ji-gu-er-yao-zi-ge-ren-zheng-hou-you-bei-fda-shou-yu-kuai-su-tong-dao-zi-ge http://www.vivabioinnovator.com/news-cn/absci-na-si-da-ke-cheng-gong-shang-shi-ci-qian-shou-gou-wei-ya-fu-hua-qi-ye-totient http://www.vivabioinnovator.com/news-cn/acelink-therapeuticsfa-bu-jian-kang-zhi-yuan-zhe-can-yu-ping-gu-al01211de-iqi-lin-chuang-shi-yan-shu-ju http://www.vivabioinnovator.com/news-cn/acelink-theraputics-yong-yu-zhi-liao-fa-bu-li-bing-de-xin-xing-gcs-yi-zhi-ji-al01211-huo-de-han-jian-bing-yao-wu-shen-pi http://www.vivabioinnovator.com/news-cn/acelink-zai-shi-jie-yan-tao-hui-shang-zhan-shi-liao-al01211-de-i-qi-lin-chuang-shu-ju-he-al00804-de-lin-chuang-qian-shu-ju http://www.vivabioinnovator.com/news-cn/acelink-zai-zhong-guo-kai-she-shou-ge-fa-bu-li-bing-fabry-disease-2-qi-lin-chuang-yan-jiu-zhong-xin http://www.vivabioinnovator.com/news-cn/acurastem-yu-wu-tian-gong-si-da-cheng-xu-ke-xie-yi-yi-tui-jin-pikfyve-zhi-liao-yao-wu http://www.vivabioinnovator.com/news-cn/aleta-biotherapeutics-xuan-bu-car-t-xi-bao-liao-fa-xian-jie-zi-aleta-001-huo-chuang-xin-hu-zhao-de-ren-ding http://www.vivabioinnovator.com/news-cn/amacathera-fei-yan-xiang-mu-ru-xuan-quickfire-challenge-bing-huo-de-zi-jin-zhi-chi http://www.vivabioinnovator.com/news-cn/amacathera-named-cix-top-20-early-company http://www.vivabioinnovator.com/news-cn/amacathera-tong-guo-amacagel-tm-ji-zhu-ping-tai-wan-cheng-iqi-lin-chuang-shi-yan-de-shou-pi-huan-zhe-gei-yao http://www.vivabioinnovator.com/news-cn/amacathera-wan-cheng-a-lun-kuo-zhan-lun-rong-zi-yong-yu-tui-dong-qi-ju-bu-chang-xiao-fei-a-pian-lei-zhi-liao-yao-wu-de-lin-chuang-kai-fa-yi-gai-shan-zhu-hou-huan-zhe-hu-li http://www.vivabioinnovator.com/news-cn/amberstone-biosciences-xuan-bu-cheng-li-ke-xue-gu-wen-wei-yuan-hui http://www.vivabioinnovator.com/news-cn/an-ji-yao-ye-anj900-huo-pi-kai-zhan-zhong-guo-guan-jian-xing-san-qi-lin-chuang-shi-yan http://www.vivabioinnovator.com/news-cn/an-ji-yao-ye-gong-bu-liang-ge-guan-jian-xiang-mu-anj908-he-anj900-de-zui-xin-jin-zhan http://www.vivabioinnovator.com/news-cn/an-ji-yao-ye-jia-su-tui-jin-gong-neng-xing-bian-mi-chuang-xin-liao-fa-ii-qi-lin-chuang-yan-jiu http://www.vivabioinnovator.com/news-cn/an-ji-yao-ye-qi-dong-zhi-liao-er-xing-tang-niao-bing-bing-fa-shen-bing-huan-zhe-de-anj900-san-qi-shi-yan http://www.vivabioinnovator.com/news-cn/an-ji-yao-ye-yu-broad-institute-lian-he-kai-fa-mcl1-yi-zhi-ji-xiang-mu http://www.vivabioinnovator.com/news-cn/an-ji-yu-php-jian-li-zhan-lue-he-zuo-xi-shou-gong-ke-gao-fa-ji-bing http://www.vivabioinnovator.com/news-cn/antag-therapeuticsxuan-bu-fdapi-zhun-qi-zhu-yao-fen-zi-at-7687de-lin-chuang-shi-yan-xin-yao-ind-shen-qing http://www.vivabioinnovator.com/news-cn/antag-therapeuticsxuan-bu-wan-cheng-8000wan-ou-yuan-alun-rong-zi http://www.vivabioinnovator.com/news-cn/arrepath-xuan-bu-huo-de-2000-wan-mei-yuan-de-chong-zi-lun-rong-zi-yi-tui-jin-qi-ji-qi-xue-xi-ping-tai-fa-xian-jie-jue-nai-yao-xing-de-xin-xing-kang-gan-ran-yao-wu http://www.vivabioinnovator.com/news-cn/arthrosi-gong-bu-tong-feng-yao-wu-ar882-lin-chuang-2a-shu-ju-liao-xiao-xian-zhu-you-yu-xian-you-yi-xian-liao-fa http://www.vivabioinnovator.com/news-cn/arthrosi-gong-bu-tong-feng-yao-wu-ar882-quan-qiu-iib-qi-lin-chuang-jie-guo-you-xiao-xing-he-an-quan-xing-liang-hao http://www.vivabioinnovator.com/news-cn/arthrosi-quan-qiu-chuang-xin-tong-feng-yao-ar882-rong-jie-tong-feng-shi-zui-xin-lin-chuang-cheng-guo-zai-mei-guo-feng-shi-bing-xue-hui-acr-2023-nian-hui-shang-fa-bu http://www.vivabioinnovator.com/news-cn/arthrosi-therapeutics-cheng-gong-huo-de-7500-wan-mei-yuan-de-d-lun-rong-zi http://www.vivabioinnovator.com/news-cn/arthrosi-therapeutics-tong-feng-yao-wu-ar882-zhun-bei-jin-ru-quan-qiu-iii-qi-yan-jiu http://www.vivabioinnovator.com/news-cn/arthrosi-therapeutics-wan-cheng-c-lun-rong-zi-jia-su-tui-jin-tong-feng-chuang-xin-yao-wu-yan-fa http://www.vivabioinnovator.com/news-cn/arthrosi-therapeutics-xuan-bu-ar882-quan-qiu-2b-qi-lin-chuang-yan-jiu-de-bing-ren-ru-zu http://www.vivabioinnovator.com/news-cn/arthrosi-therapeutics-yu-yi-pin-hong-yao-ye-zhan-kai-zhan-lue-he-zuo http://www.vivabioinnovator.com/news-cn/arthrosi-wan-cheng-tong-feng-yao-wu-ar882-shen-sun-shang-de-lin-chuang-yan-jiu http://www.vivabioinnovator.com/news-cn/bai-du-fei-jiang-luo-xuan-jiang-he-suo-zhi-sheng-wu-zhan-kai-shen-du-he-zuo-zhi-li-kai-fa-ai-xiao-fen-zi-yao-wu-fa-xian-he-you-hua-ti-xi-jian-she http://www.vivabioinnovator.com/news-cn/basking-biosciences-jiang-zai-isc-2023-shang-gong-bu-quan-qiu-shou-kuan-ke-ni-xing-rong-shuan-yao-wu-de-lin-chuang-shi-yan-jie-guo http://www.vivabioinnovator.com/news-cn/basking-yu-2023-guo-ji-nao-zu-zhong-da-hui-shang-zhan-shi-liao-quan-qiu-shou-kuan-ke-ni-xing-rong-shuan-ji-de-an-quan-xing-he-ji-liang-pa-po-yan-jiu-de-ji-ji-lin-chuang-jie-guo http://www.vivabioinnovator.com/news-cn/baskingxuan-bu-wan-cheng-you-archling-tou-de-5500wan-mei-yuan-rong-zi-jia-su-ke-ni-rong-shuan-ji-de-lin-chuang-kai-fa http://www.vivabioinnovator.com/news-cn/bi-chen-yi-yao-abm-therapeutics-ji-jiang-liang-xiang-2020-mei-guo-yan-zheng-yan-jiu-xue-hui-nian-hui http://www.vivabioinnovator.com/news-cn/bi-chen-yi-yao-abm-therapeutics-ji-jiang-liang-xiang-2020-mei-guo-yan-zheng-yan-jiu-xue-hui-nian-hui-2 http://www.vivabioinnovator.com/news-cn/bi-chen-yi-yao-abm-therapeutics-wan-cheng-liang-qian-wan-mei-yuan-a-lun-rong-zi http://www.vivabioinnovator.com/news-cn/bi-chen-yi-yao-he-san-sheng-guo-jian-xuan-bu-da-cheng-zhan-lue-he-zuo-jia-su-tui-jin-chuang-xin-yao-wu-de-yan-fa http://www.vivabioinnovator.com/news-cn/bi-chen-yi-yao-ke-ru-nao-mek-yi-zhi-ji-abm-168-huo-mei-guo-fda-lin-chuang-shi-yan-xu-ke http://www.vivabioinnovator.com/news-cn/bi-chen-yi-yao-mek-yi-zhi-ji-abm-168-ind-huo-zhong-guo-guo-jia-yao-jian-ju-pi-zhun http://www.vivabioinnovator.com/news-cn/bi-chen-yi-yao-xuan-bu-abm-1310-zai-mei-guo-yi-qi-lin-chuang-shi-yan-shou-li-bing-ren-cheng-gong-yong-yao http://www.vivabioinnovator.com/news-cn/bi-chen-yi-yao-xuan-bu-abm-1310-zai-mei-guo-yi-qi-lin-chuang-shi-yan-shou-li-bing-ren-cheng-gong-yong-yao-2 http://www.vivabioinnovator.com/news-cn/bi-chen-yi-yao-xuan-bu-abm-1310-zai-zhong-guo-i-qi-lin-chuang-shi-yan-shou-li-bing-ren-cheng-gong-yong-yao http://www.vivabioinnovator.com/news-cn/bi-chen-yi-yao-xuan-bu-abm-1310-zai-zhong-guo-zhen-dui-yuan-fa-xing-e-xing-nao-zhong-liu-de-i-qi-lin-chuang-shi-yan-shou-li-bing-ren-cheng-gong-yong-yao http://www.vivabioinnovator.com/news-cn/bi-chen-yi-yao-xuan-bu-abm-168-zai-mei-guo-i-qi-lin-chuang-shi-yan-shou-li-bing-ren-cheng-gong-yong-yao http://www.vivabioinnovator.com/news-cn/bo-zhi-sheng-wu-wan-cheng-1800wan-mei-yuan-alun-rong-zi http://www.vivabioinnovator.com/news-cn/chuang-xin-zhi-yuan-2022-biotech-chuang-shi-ren-xu-li-ji-jie-zai-chu-fa-gun-di-san-jie-wei-ya-sheng-wu-chuang-xin-he-zuo-gao-feng-hui-shi-lu http://www.vivabioinnovator.com/news-cn/cybrexa-he-exelixis-da-cheng-du-jia-he-zuo-wei-exelixis-ti-gong-shou-gou-cbx-12-de-quan-li http://www.vivabioinnovator.com/news-cn/cybrexa-therapeutics-announces-data-demonstrating-early-signals-of-efficacy-and-powerful-potential-of-antigen-independent-tumor-targeting http://www.vivabioinnovator.com/news-cn/cybrexazai-2024-esmoda-hui-shang-xuan-bu-duo-tai-ou-lian-yao-wu-cbx-12zai-wan-qi-shi-ti-liu-zhong-1qi-yan-jiu-de-ji-ji-zui-zhong-shu-ju http://www.vivabioinnovator.com/news-cn/deka-biosciences-raises-usd-20-million-in-series-a-financing http://www.vivabioinnovator.com/news-cn/deka-biosciences-wan-cheng-you-mpm-bioimpact-ling-tou-de-2-000-wan-mei-yuan-b2-lun-rong-zi http://www.vivabioinnovator.com/news-cn/domain-therapeutics-huo-de-mo-ke-gong-si-shu-bai-wan-mei-jin-de-li-cheng-bei-fu-kuan-yong-yu-mian-yi-zhong-liu-xue-ling-yu-yao-wu-m1069-lin-chuang-kai-fa http://www.vivabioinnovator.com/news-cn/domain-therapeutics-wan-cheng-4200-wan-mei-yuan-a-lun-rong-zi http://www.vivabioinnovator.com/news-cn/domain-therapeutics-xuan-bu-ti-ming-shou-chuang-par2-nam-hou-xuan-yao-wu-dt-9045 http://www.vivabioinnovator.com/news-cn/domain-yong-yu-zhi-liao-shi-ti-liu-de-ep4r-jie-kang-ji-dt-9081-huo-pi-jin-ru-lin-chuang http://www.vivabioinnovator.com/news-cn/dtx-pharma-xuan-bu-yu-nuo-hua-da-cheng-shou-gou-xie-yi http://www.vivabioinnovator.com/news-cn/fda-shou-yu-bi-chen-yi-yao-abm-1310-gu-er-yao-zi-ge-ren-zheng-yong-yu-zhi-liao-xi-dai-braf-v600-tu-bian-de-nao-xiao-zhi-mu-xi-bao-liu-huan-zhe http://www.vivabioinnovator.com/news-cn/focus-x-therapeutics-zhuan-fang-cheng-li-duan-duan-liang-nian-nei-cheng-gong-da-cheng-shou-gou-zhe-jia-he-su-yao-wu-chu-chuang-qi-ye-you-he-te-bie-zhi-chu http://www.vivabioinnovator.com/news-cn/fu-lian-ke-ji-yu-sk-biopharmaceuticalsjiu-ba-xiang-duo-zhong-shi-ti-liu-de-chuang-xin-liao-fa-qian-shu-xu-ke-xie-yi http://www.vivabioinnovator.com/news-cn/fuse-biotherapeutics-chao-e-wan-cheng-a-lun-rong-zi http://www.vivabioinnovator.com/news-cn/gao-da-7-86yi-mei-yuan-mediaryu-li-lai-da-cheng-he-zuo-tui-jin-yong-yu-zhi-liao-te-fa-xing-fei-xian-wei-hua-ipf-de-shou-chuang-kang-ti-wisp1 http://www.vivabioinnovator.com/news-cn/haya-therapeutics-cheng-gong-ru-xuan-2022-nian-rui-shi-bai-qiang-chu-chuang-qi-ye-he-soonicornclub-2022 http://www.vivabioinnovator.com/news-cn/hayaxuan-bu-yu-li-lai-da-cheng-he-zuo-gong-tong-li-yong-zhuan-you-rnaping-tai-fa-xian-zhi-liao-fei-pang-ji-xiang-guan-dai-xie-ji-bing-de-xin-xing-diao-kong-ji-yin-zu-ba-dian http://www.vivabioinnovator.com/news-cn/heng-rui-yi-yao-a-pa-ti-ni-lian-he-qi-yu-sheng-wu-q-1802-zhi-liao-wan-qi-wei-yan-de-ii-qi-lin-chuang-yan-jiu-da-cheng-zhan-lue-he-zuo http://www.vivabioinnovator.com/news-cn/innovation-partnership-growth-wei-ya-sheng-wu-chuang-xin-he-zuo-gao-feng-hui-yu-shang-hai-cheng-gong-ju-ban-2 http://www.vivabioinnovator.com/news-cn/ipinovyx-bio-wan-cheng-1000-wan-mei-yuan-chong-zi-rong-zi-kai-fa-mian-yi-dan-bai-mei-yi-zhi-ji http://www.vivabioinnovator.com/news-cn/jia-su-chuang-xin-shen-du-zheng-he-wei-ya-sheng-wu-2020-xian-shang-tou-zi-zhe-kai-fang-ri-hui-gu http://www.vivabioinnovator.com/news-cn/join-vbi-and-j-j-on-dec-8-with-the-the-dos-donts-of-fundraising http://www.vivabioinnovator.com/news-cn/ju-jiao-chuang-xin-fu-neng-he-zuo-gun-di-san-jie-wei-ya-sheng-wu-chuang-xin-he-zuo-gao-feng-hui http://www.vivabioinnovator.com/news-cn/ju-jiao-he-cheng-zhi-si-pai-long-sheng-wu-chu-shou-cdk7yi-zhi-ji-quan-yi http://www.vivabioinnovator.com/news-cn/lang-hua-zhi-yao-cmc-ye-wu-zhan-lu-tou-jiao-zhu-li-wei-mou-sheng-wu-chuang-xin-yao-yan-fa http://www.vivabioinnovator.com/news-cn/lang-hua-zhi-yao-sun-jing-shun-yao-wu-fen-xi-xin-ji-zhu-fu-neng-yan-fa-chuang-xin http://www.vivabioinnovator.com/news-cn/liang-zhun-liang-xiang-di-san-jie-zhong-guo-guo-ji-jin-kou-zhan-lan-hui http://www.vivabioinnovator.com/news-cn/lin-chuang-jie-duan-sheng-wu-zhi-yao-gong-si-te-ke-luo-zui-xin-jin-zhan-xiong-tuo-guan-xian-bu-ru-ii-qi-lin-chuang http://www.vivabioinnovator.com/news-cn/lin-chuang-xiang-mu-tui-jin-ji-ji-te-ke-luo-huo-wan-wu-chuang-tou-shu-bai-wan-mei-yuan-pre-blun-rong-zi http://www.vivabioinnovator.com/news-cn/lucy-therapeuticshuo-de-xin-yi-lun-rong-zi-yi-tui-jin-a-er-ci-hai-mo-zheng-he-pa-jin-sen-zheng-zhi-liao-xin-fang-fa http://www.vivabioinnovator.com/news-cn/mediar-therapeutics-xuan-bu-wan-cheng-1-05-yi-mei-yuan-de-rong-zi-yi-tui-jin-shou-chuang-kang-xian-wei-hua-liao-fa http://www.vivabioinnovator.com/news-cn/pai-long-sheng-wu-wan-cheng-1750-wan-mei-yuan-a-lun-rong-zi-bing-yu-wei-ya-sheng-wu-jian-li-xin-de-zhan-lue-he-zuo-huo-ban-guan-xi http://www.vivabioinnovator.com/news-cn/phenomic-ai-li-yong-ai-ji-zhu-fu-neng-sheng-wu-yi-yao http://www.vivabioinnovator.com/news-cn/phenomic-ai-yu-an-si-tai-lai-jiu-shi-ti-liu-xi-bao-liao-fa-kai-zhan-zhan-lue-yan-jiu-he-zuo http://www.vivabioinnovator.com/news-cn/phenomic-ai-yu-bo-lin-ge-yin-ge-han-da-cheng-zhan-lue-he-zuo-gong-tong-tan-suo-gua-yong-yu-ji-zhi-feng-fu-yan-zheng-liao-fa-de-xin-xing-ba-dian http://www.vivabioinnovator.com/news-cn/qi-yu-sheng-wu-jiang-yu-2022-nian-asco-nian-hui-shang-gong-bu-qi-q-1802-de-zui-xin-lin-chuang-shu-ju http://www.vivabioinnovator.com/news-cn/qi-yu-sheng-wu-q-1802-ind-shen-qing-huo-fda-pi-zhun http://www.vivabioinnovator.com/news-cn/qi-yu-sheng-wu-q-1802-lin-chuang-shen-qing-huo-guo-jia-yao-shen-zhong-xin-shou-li http://www.vivabioinnovator.com/news-cn/qi-yu-sheng-wu-shou-ge-shuang-te-yi-xing-kang-ti-q-1802-lian-he-yong-yao-lin-chuang-shi-yan-i-ii-qi-huo-pi http://www.vivabioinnovator.com/news-cn/qi-yu-sheng-wu-shuang-te-yi-xing-kang-ti-q-1802-xiang-mu-ru-xuan-shang-hai-shi-2023-nian-ke-ji-xing-zhong-xiao-qi-ye-chuang-xin-zi-jin-ji-hua http://www.vivabioinnovator.com/news-cn/qi-yu-sheng-wu-wan-cheng-shu-qian-wan-yuan-a-lun-rong-zi-tui-jin-zhong-liu-mian-yi-shuang-kang-yao-wu-lin-chuang-qian-kai-fa http://www.vivabioinnovator.com/news-cn/qi-yu-sheng-wu-wan-cheng-shu-qian-wan-yuan-a-lun-rong-zi-tui-jin-zhong-liu-mian-yi-shuang-kang-yao-wu-lin-chuang-qian-kai-fa-2 http://www.vivabioinnovator.com/news-cn/qin-hao-yi-yao-shp2-yi-zhi-ji-gh21-lian-yong-egfr-yi-zhi-ji-ao-xi-ti-ni-huo-pi-lin-chuang http://www.vivabioinnovator.com/news-cn/qin-hao-yi-yao-xin-yi-dai-prmt5yi-zhi-ji-gh56lin-chuang-shi-yan-shen-qing-huo-nmpapi-zhun http://www.vivabioinnovator.com/news-cn/quralis-ru-xuan-fierce-biotechs-2020-fierce-15-bang-dan http://www.vivabioinnovator.com/news-cn/quralis-shou-xi-zhi-xing-guan-kasper-roet-bo-shi-huo-xuan-2022-henri-termeer-award http://www.vivabioinnovator.com/news-cn/quralis-wan-cheng-4200-wan-mei-yuan-a-lun-mu-zi-zhuan-zhu-yan-fa-zhi-yu-shen-jing-tui-xing-xing-ji-bing-de-chuang-xin-liao-fa http://www.vivabioinnovator.com/news-cn/quralisxuan-bu-yu-li-lai-da-cheng-asoliao-fa-qrl-204de-quan-qiu-du-jia-xu-ke-xie-yi http://www.vivabioinnovator.com/news-cn/regenacy-xuan-bu-wan-cheng-ricolinostat-tang-niao-bing-zhou-wei-shen-jing-bing-bian-er-qi-lin-chuang-ru-zu-he-930-wan-mei-yuan-b-lun-rong-zi http://www.vivabioinnovator.com/news-cn/riparian-pharmaceuticals-xuan-bu-yu-hui-rui-da-cheng-xin-xie-guan-xiang-mu-du-jia-xu-ke-xie-yi-he-yan-jiu-xie-yi http://www.vivabioinnovator.com/news-cn/seraxisxuan-bu-huo-de-fdapi-zhun-sr-02ti-dai-yi-dao-su-yong-yu-1xing-tang-niao-bing-de-lin-chuang-yan-jiu http://www.vivabioinnovator.com/news-cn/simon-sturge-joins-mediar-therapeutics-as-executive-chairman http://www.vivabioinnovator.com/news-cn/suo-zhi-sheng-wu-yu-bai-du-fei-jiang-luo-xuan-jiang-shen-du-he-zuo-zheng-he-cheng-yao-xing-yu-ce-fang-fa-jia-su-xin-yao-yan-fa http://www.vivabioinnovator.com/news-cn/suo-zhi-sheng-wu-yu-qing-hua-da-xue-mian-yi-xue-yan-jiu-suo-he-zuo-tan-suo-he-tui-dong-zi-mian-ling-yu-xin-yao-yan-fa http://www.vivabioinnovator.com/news-cn/te-ke-luo-qi-dong-zhen-dui-te-ying-xing-pi-yan-shi-zhen-tdm-180935xin-yao-de-2qi-lin-chuang-shi-yan http://www.vivabioinnovator.com/news-cn/te-ke-luo-sheng-wu-wan-cheng-shu-qian-wan-yuan-a-lun-rong-zi http://www.vivabioinnovator.com/news-cn/te-ke-luo-sheng-wu-xuan-bu-tdm-105795-zai-mei-i-qi-lin-chuang-shi-yan-xin-jin-zhan http://www.vivabioinnovator.com/news-cn/te-ke-luo-wan-cheng-yong-yu-zhi-liao-te-ying-xing-pi-yan-de-tdm-180935wai-yong-ruan-gao-zai-mei-guo-jin-xing-de-iiaqi-gai-nian-yan-zheng-lin-chuang-shi-yan http://www.vivabioinnovator.com/news-cn/te-ke-luo-wan-cheng-zhen-dui-shi-zhen-pi-yan-gua-ying-zheng-de-tdm-180935ji-liang-di-zeng-de-yi-qi-lin-chuang-shi-yan http://www.vivabioinnovator.com/news-cn/te-ke-luo-zai-yan-xin-yao-pi-lu-xin-jin-zhan-te-ying-xing-pi-yan-xiao-fen-zi-yao-wu-kai-qi-ji-liang-di-zeng-yi-qi-lin-chuang-shi-yan http://www.vivabioinnovator.com/news-cn/te-ke-luo-zhi-liao-xiong-ji-su-xing-tuo-fa-quan-qiu-shou-chuang-xin-yao-lin-chuang-er-qi-ashi-yan-zheng-shi-tdm-105795cu-jin-xiong-ji-su-xing-tuo-fa-huan-zhe-mao-fa-sheng-chang http://www.vivabioinnovator.com/news-cn/tian-jing-sheng-wu-xuan-bu-cd38kang-ti-fei-ze-tuo-dan-kang-shang-shi-shen-qing-huo-nmpashou-li http://www.vivabioinnovator.com/news-cn/tian-jing-sheng-wu-yu-ji-chuan-yao-ye-lian-he-xuan-bu-yi-tan-chang-xiao-sheng-chang-ji-su-shang-shi-shen-qing-yi-huo-shou-li http://www.vivabioinnovator.com/news-cn/tian-jing-sheng-wu-yu-sai-nuo-fei-jiu-quan-qiu-chuang-xin-cd73ba-xiang-zhong-liu-liao-fa-da-cheng-da-zhong-hua-qu-zhan-lue-he-zuo http://www.vivabioinnovator.com/news-cn/tong-xin-kang-yi-wei-ya-sheng-wu-zhu-li-kou-fu-xin-guan-yao-wu-sheng-chan-ji-bing-du-jian-ce http://www.vivabioinnovator.com/news-cn/triumvira-guan-xuan-wan-cheng-a-lun-rong-zi-zong-ji-wan-cheng-liao-jin-100m-de-a-lun-rong-zi http://www.vivabioinnovator.com/news-cn/triumvira-jiang-wei-yan-zheng-zhi-liao-ti-gong-yi-chong-quan-xin-de-tcr-t-xi-bao-liao-fa-mu-qian-yi-jing-wan-cheng-phase1-shou-li-bing-ren-de-gei-yao http://www.vivabioinnovator.com/news-cn/triumvira-yu-mo-ke-jian-li-he-zuo-guan-xi-ping-gu-tac01-her2-xi-bao-liao-fa-lian-he-ke-rui-da-zhi-liao-her2-yang-xing-shi-ti-liu http://www.vivabioinnovator.com/news-cn/vbi-demo-day-2-huo-dong-hui-gu-bian-ge-zhi-xia-zao-qi-sheng-wu-yi-yao-kua-jing-tou-zi-zhan-wang http://www.vivabioinnovator.com/news-cn/vbi-jia-li-fu-ni-ya-zhou-zhi-lu-2 http://www.vivabioinnovator.com/news-cn/vbi-newshub-gun-dtx-pharma-yong-yu-zhi-liao-cmt1a-de-dtx-1252-huo-fda-gu-er-yao-ren-ding http://www.vivabioinnovator.com/news-cn/viva-bioinnovator-yu-newyorkbio-biocom-california-tou-zi-zhe-jian-mian-hui http://www.vivabioinnovator.com/news-cn/vvn461-yong-yu-zhi-liao-bai-nei-zhang-zhu-hou-yan-zheng-de-ii-qi-lin-chuang-shi-yan-shen-qing-zheng-shi-huo-de-mei-guo-fda-pi-zhun http://www.vivabioinnovator.com/news-cn/wei-mou-sheng-wu-fei-ji-su-di-yan-ye-vvn461zhi-liao-qian-pu-tao-mo-yan-zhong-guo-lin-chuang-2qi-yan-jiu-da-dao-lin-chuang-zhong-dian http://www.vivabioinnovator.com/news-cn/wei-mou-sheng-wu-fei-ji-su-di-yan-ye-vvn461zhi-liao-shu-hou-yan-zheng-mei-guo-lin-chuang-2qi-yan-jiu-da-dao-lin-chuang-zhong-dian http://www.vivabioinnovator.com/news-cn/wei-mou-sheng-wu-gan-yan-zheng-chuang-xin-yao-vvn001-mei-guo-ii-qi-lin-chuang-shi-yan-jie-guo-ji-ji http://www.vivabioinnovator.com/news-cn/wei-mou-sheng-wu-jiang-yu-everads-he-zuo-kai-fa-chang-xiao-shi-wang-mo-ji-bing-zhi-liao-yao-wu http://www.vivabioinnovator.com/news-cn/wei-mou-sheng-wu-ke-ji-shang-hai-you-xian-gong-si-lfa1-yi-zhi-ji-vvn001-di-jiao-mei-guo-lin-chuang-ii-qi-shi-yan-shen-qing http://www.vivabioinnovator.com/news-cn/wei-mou-sheng-wu-tong-tai-jin-sheng-wu-xuan-bu-zhan-lue-he-zuo-guan-xi-zhu-li-kai-fa-yan-di-ji-bing-xiang-guan-de-kang-ti-yao-wu http://www.vivabioinnovator.com/news-cn/wei-mou-sheng-wu-wan-cheng-3-yi-yuan-ren-min-bi-d-lun-rong-zi http://www.vivabioinnovator.com/news-cn/wei-mou-sheng-wu-xuan-bu-wan-cheng-yu-yi-yuan-d2-lun-rong-zi http://www.vivabioinnovator.com/news-cn/wei-mou-sheng-wu-yong-yu-zhi-liao-qing-guang-yan-de-shuang-ba-dian-ji-zhi-vvn539-zheng-shi-di-jiao-mei-guo-ii-qi-lin-chuang-shi-yan-shen-qing http://www.vivabioinnovator.com/news-cn/wei-mou-sheng-wu-zi-zhu-yan-fa-de-qing-guang-yan-shuang-ba-dian-chuang-xin-yao-vvn539-mei-guo-ii-qi-lin-chuang-da-dao-zhu-yao-yan-jiu-zhong-dian http://www.vivabioinnovator.com/news-cn/wei-ya-sheng-wu-1873-hk-huo-na-ru-msci-zhong-guo-xiao-xing-gu-zhi-shu http://www.vivabioinnovator.com/news-cn/wei-ya-sheng-wu-3-jia-tou-zi-fu-hua-gong-si-jin-qi-fa-zhan-dong-tai-yi-lan http://www.vivabioinnovator.com/news-cn/wei-ya-sheng-wu-5-jia-tou-zi-fu-hua-gong-si-jin-qi-fa-zhan-dong-tai-yi-lan http://www.vivabioinnovator.com/news-cn/wei-ya-sheng-wu-6-jia-tou-zi-fu-hua-gong-si-jin-qi-fa-zhan-dong-tai-yi-lan http://www.vivabioinnovator.com/news-cn/wei-ya-sheng-wu-7-jia-tou-zi-fu-hua-gong-si-jin-qi-fa-zhan-dong-tai-yi-lan http://www.vivabioinnovator.com/news-cn/wei-ya-sheng-wu-cbo-xu-da-qiang-bo-shi-zai-bo-shi-dun-can-jia-resi-zhong-guo-kua-jing-he-zuo-hui-yi-2 http://www.vivabioinnovator.com/news-cn/wei-ya-sheng-wu-chuang-xin-zhong-xin-huo-pu-dong-xin-qu-da-qi-ye-kai-fang-chuang-xin-zhong-xin-shou-pi-shou-pai http://www.vivabioinnovator.com/news-cn/wei-ya-sheng-wu-fa-bu-2020-nian-du-quan-nian-ye-ji-shou-ru-tong-bi-shang-zhang-115-7-cfs-ye-wu-shou-ru-da-fu-zeng-chang-146-3 http://www.vivabioinnovator.com/news-cn/wei-ya-sheng-wu-fa-bu-2020-zhong-qi-ye-ji-ji-ji-gou-jian-yi-zhan-shi-zong-he-yao-wu-fu-wu-ping-tai http://www.vivabioinnovator.com/news-cn/wei-ya-sheng-wu-fa-bu-2021-nian-du-ye-ji http://www.vivabioinnovator.com/news-cn/wei-ya-sheng-wu-fa-bu-2021-zhong-qi-ye-ji http://www.vivabioinnovator.com/news-cn/wei-ya-sheng-wu-fa-bu-2022-nian-du-ye-ji-shou-ru-mao-li-shuang-xiang-zeng-chang-yi-ti-hua-ping-tai-jing-zheng-you-shi-bu-duan-xian-xian http://www.vivabioinnovator.com/news-cn/wei-ya-sheng-wu-jin-qi-xing-ye-can-hui-su-lan http://www.vivabioinnovator.com/news-cn/wei-ya-sheng-wu-jin-qi-xing-ye-can-hui-su-lan-2 http://www.vivabioinnovator.com/news-cn/wei-ya-sheng-wu-mao-chen-zai-sheng-wu-ke-ji-ling-yu-wei-da-de-xiang-fa-hui-cui-sheng-chu-cheng-gong-de-qi-ye-jia-2 http://www.vivabioinnovator.com/news-cn/wei-ya-sheng-wu-rong-huo-dong-mai-peng-cheng-jiang-nian-du-ling-xiu-qi-ye-zhu-tui-chuang-xin-yao-cong-0-dao-1-jie-zhi-chuang-zao-ji-fa-xian-2 http://www.vivabioinnovator.com/news-cn/wei-ya-sheng-wu-sheng-di-ya-ge-sheng-wu-yi-yao-chuang-ye-zhao-dai-hui http://www.vivabioinnovator.com/news-cn/wei-ya-sheng-wu-tou-zi-fu-hua-gong-si-focus-x-therapeutics-yu-fu-lian-yi-yao-cheng-gong-da-cheng-shou-gou-xie-yi http://www.vivabioinnovator.com/news-cn/wei-ya-sheng-wu-tou-zi-fu-hua-gong-si-jin-qi-fa-zhan-dong-tai-yi-lan http://www.vivabioinnovator.com/news-cn/wei-ya-sheng-wu-tou-zi-fu-hua-gong-si-jin-qi-fa-zhan-dong-tai-yi-lan-10 http://www.vivabioinnovator.com/news-cn/wei-ya-sheng-wu-tou-zi-fu-hua-gong-si-jin-qi-fa-zhan-dong-tai-yi-lan-11 http://www.vivabioinnovator.com/news-cn/wei-ya-sheng-wu-tou-zi-fu-hua-gong-si-jin-qi-fa-zhan-dong-tai-yi-lan-12 http://www.vivabioinnovator.com/news-cn/wei-ya-sheng-wu-tou-zi-fu-hua-gong-si-jin-qi-fa-zhan-dong-tai-yi-lan-2 http://www.vivabioinnovator.com/news-cn/wei-ya-sheng-wu-tou-zi-fu-hua-gong-si-jin-qi-fa-zhan-dong-tai-yi-lan-3 http://www.vivabioinnovator.com/news-cn/wei-ya-sheng-wu-tou-zi-fu-hua-gong-si-jin-qi-fa-zhan-dong-tai-yi-lan-4 http://www.vivabioinnovator.com/news-cn/wei-ya-sheng-wu-tou-zi-fu-hua-gong-si-jin-qi-fa-zhan-dong-tai-yi-lan-5 http://www.vivabioinnovator.com/news-cn/wei-ya-sheng-wu-tou-zi-fu-hua-gong-si-jin-qi-fa-zhan-dong-tai-yi-lan-6 http://www.vivabioinnovator.com/news-cn/wei-ya-sheng-wu-tou-zi-fu-hua-gong-si-jin-qi-fa-zhan-dong-tai-yi-lan-7 http://www.vivabioinnovator.com/news-cn/wei-ya-sheng-wu-tou-zi-fu-hua-gong-si-jin-qi-fa-zhan-dong-tai-yi-lan-8 http://www.vivabioinnovator.com/news-cn/wei-ya-sheng-wu-tou-zi-fu-hua-gong-si-jin-qi-fa-zhan-dong-tai-yi-lan-9 http://www.vivabioinnovator.com/news-cn/wei-ya-sheng-wu-xi-shou-schrodinger-jiu-gong-tong-yan-fa-quan-xin-ba-dian-jie-gou-da-cheng-zhan-lue-he-zuo-2 http://www.vivabioinnovator.com/news-cn/wei-ya-sheng-wu-xi-shou-shang-hai-sheng-wu-yi-yao-ji-jin-gong-jian-yi-liao-chuang-xin-cheng-guo-zhuan-hua-ping-tai http://www.vivabioinnovator.com/news-cn/wei-ya-sheng-wu-xu-da-qiang-bo-shi-chuang-xin-yao-bi-xu-qie-shi-jie-jue-wei-man-zu-de-lin-chuang-xu-qiu-2 http://www.vivabioinnovator.com/news-cn/wei-ya-sheng-wu-yu-lang-hua-zhi-yao-da-cheng-zhan-lue-zheng-he-xie-yi-jia-su-sheng-ji-chuang-xin-yao-chan-ye-fu-wu-lian http://www.vivabioinnovator.com/news-cn/wei-ya-sheng-wu-zan-zhu-de-sabpa-e-club-yao-wu-hua-xue-yan-tao-hui-shun-li-zhao-kai-2 http://www.vivabioinnovator.com/news-cn/wei-ya-sheng-wu-zhan-lue-shou-gou-synthesis-jia-su-tuo-zhan-quan-qiu-chuang-xin-yao-yan-fa-fu-wu-neng-li http://www.vivabioinnovator.com/news-cn/xiang-ju-jpm-jian-kang-da-hui-yu-wei-ya-gong-hua-sheng-wu-yi-yao-chuang-xin-yu-he-zuo http://www.vivabioinnovator.com/news-cn/xun-qiu-jie-jue-zhong-feng-zhi-liao-zhong-zui-da-de-wen-ti http://www.vivabioinnovator.com/news-cn/yao-qing-han-demo-day-2021-qiang-shi-hui-gui http://www.vivabioinnovator.com/news-cn/yi-tu-du-dong-wei-ya-sheng-wu-2022-nian-du-ye-ji http://www.vivabioinnovator.com/news-cn/yi-tu-du-dong-wei-ya-sheng-wu-ke-ji-kong-gu-ji-tuan-gu-fen-dai-hao-1873-hk-2020-nian-zhong-qi-ye-ji http://www.vivabioinnovator.com/news-cn/yi-tu-du-dong-wei-ya-sheng-wu-shou-fen-huan-jing-she-hui-ji-guan-zhi-bao-gao http://www.vivabioinnovator.com/news-cn/yi-tuo-chuang-xin-yao-kai-fa-ce-lue-quralis-wan-cheng-8800-wan-mei-yuan-b-lun-rong-zi